Preclinical and translational research services in immuno-oncology, including target discovery, validation, in vitro and in vivo preclinical services, and clinical biomarker discovery and analysis.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including Explicyte's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: June 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
QIMA Life Sciences
B
Preclinical and clinical research services for cosmetic, nutraceutical, and pharmaceutical industries, including in vitro, ex vivo, and clinical solutions.
Cerba Research
B
Provides specialized lab solutions for clinical research, including biomarker services, immunoassays, and centralized lab management. Supports clinical trials in various therapeutic areas, with expertise in oncology, metabolic diseases, inflammation, immunology, infectious diseases, autoimmune diseases, and rare diseases.
ERBC
A
Preclinical contract research organization (CRO) offering in vitro and in vivo models, toxicology, safety pharmacology, and laboratory services for drug, chemical, and food product development.
Initiatives identified among leaders
Rapport RSE détaillant engagements sociaux et environnementaux des activités.
“Cerba Research publie un rapport RSE (Responsabili...” - Cerba ResearchPublication de données environnementales et éthiques dans un rapport annuel
“Le rapport de durabilité 2024 présente des indicat...” - Cerba ResearchScore élevé Index égalité femmes-hommes en 2025.
“QIMA Life Sciences a obtenu un score de 81/100 pou...” - QIMA Life Sciences52% of similar organizations communicate on CSR issues
+161 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports